• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4780123)   Today's Articles (3915)
For: Wölfler A, Abuja PM, Linkesch W, Schauenstein K, Liebmann PM. Questionable benefit of melatonin for antioxidant pharmacologic therapy. J Clin Oncol 2002;20:4127-8; author reply 4128-9. [PMID: 12351615 DOI: 10.1200/jco.2002.99.158] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
Number Cited by Other Article(s)
1
Reiter RJ, Tan DX, Herman TS, Thomas CR. Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys 2004;59:639-53. [PMID: 15183467 DOI: 10.1016/j.ijrobp.2004.02.006] [Citation(s) in RCA: 212] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2003] [Revised: 01/14/2004] [Accepted: 02/06/2004] [Indexed: 11/23/2022]
2
Tassinari D, Panzini I, Sartori S, Ravaioli A. Surrogate outcomes in quality-of-life research: where will we end up? J Clin Oncol 2003;21:1894-5; author reply 1895. [PMID: 12721275 DOI: 10.1200/jco.2003.99.244] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
3
Sloan JA. Quality-of-life meta-analysis: why treat it differently? J Clin Oncol 2003;21:1422. [PMID: 12663740 DOI: 10.1200/jco.2003.99.037] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA